Interstitial Cystitis
Conditions
Brief summary
For each patient in the study, blood, and pain scores will be collected to look for markers for pain, at the start of treatment and 6 months after surgery of treatment.
Detailed description
The study is investigator-initiated, prospective, study. There will be no change in care. Patients who have had a diagnosis of IC made by cystoscopy and hydrodistension and still have pain will be recruited for this study. Patients will have blood samples taken at the visit they sign the consent form and 6 months later. The study staff will call and remind the patient of their 6 month visit.
Interventions
QOL and pain questionnaires will be given to patients at 3, 6, and 12 months post surgery
Blood for PBLs will be collected at 3, 6, and 12 months post surgery
Sponsors
Study design
Eligibility
Inclusion criteria
* 18-70 years of age * Patients must be able to provide written informed consent. * Diagnosis of Interstitial Cystitis documented by provider
Exclusion criteria
* age \<18 or \>70 years of age * pregnant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change From Baseline in Pain Scores on the Visual Analog Scale at 6 months | 3 months | S1PR1 levels in PBLs can discriminate patients with Interstitial Cystitis pain and patients with other types of pain. |
Countries
United States